NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,436 | +4.1% | 6,955 | +3.1% | 0.19% | +3.2% |
| Q2 2023 | $680,436 | -2.3% | 6,743 | -10.9% | 0.18% | -5.1% |
| Q1 2023 | $696,624 | +8.3% | 7,572 | +6.8% | 0.20% | +2.1% |
| Q4 2022 | $643,477 | +135.7% | 7,093 | +97.2% | 0.19% | +112.2% |
| Q3 2022 | $273,000 | -11.4% | 3,597 | -1.2% | 0.09% | -10.9% |
| Q2 2022 | $308,000 | -15.2% | 3,640 | -12.0% | 0.10% | -10.6% |
| Q1 2022 | $363,000 | +6.1% | 4,136 | +5.0% | 0.11% | -0.9% |
| Q4 2021 | $342,000 | +25.7% | 3,939 | +18.4% | 0.11% | +14.0% |
| Q3 2021 | $272,000 | -0.7% | 3,326 | +10.7% | 0.10% | -9.1% |
| Q2 2021 | $274,000 | +10.0% | 3,005 | +3.0% | 0.11% | -5.2% |
| Q1 2021 | $249,000 | -0.8% | 2,917 | +9.9% | 0.12% | -6.5% |
| Q4 2020 | $251,000 | +17.3% | 2,655 | +7.9% | 0.12% | -0.8% |
| Q3 2020 | $214,000 | -0.5% | 2,461 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $215,000 | – | 2,461 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |